Credit Suisse’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Credit Suisse’s Portfolio CBST Stock Details CBST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-311,260	Closed	-$31.3M	–	4808
2014 Q4	$31.3M	Buy	311,260 +101,965	+49%	+$7.93M	0.03%	666
2014 Q3	$13.9M	Sell	209,295 -3,718	-2%	-$244K	0.01%	1110
2014 Q2	$14.9M	Buy	213,013 +45,971	+28%	+$3.13M	0.01%	1123
2014 Q1	$12.2M	Sell	167,042 -33,547	-17%	-$2.5M	0.01%	1126
2013 Q4	$13.8M	Sell	200,589 -72,533	-27%	-$4.7M	0.01%	1039
2013 Q3	$17.4M	Buy	273,122 +69,005	+34%	+$4.17M	0.02%	815
2013 Q2	$9.86M	Buy	+204,117	New	+$10M	0.01%	1139

Credit Suisse's CBST Position: Q1 2015 in Review

Credit Suisse sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 311,260 shares — an estimated $31.3M sold.

Credit Suisse first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $31.3M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

Credit Suisse reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
Credit Suisse sold 311,260 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $31.3M.
Credit Suisse first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
Credit Suisse's CUBIST PHARMACEUTICALS INC position peaked at $31.3M in Q4 2014.
0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Credit Suisse's 13F filing for Q1 2015, filed 6 May 2015.